The University of Surrey has conferred an Honorary Doctorate upon Professor Langley, in recognition of his pioneering contributions to prostate cancer detection and treatment, and his leadership in advancing research and care across Surrey and beyond.
The award was presented during a formal graduation ceremony, where Professor Langley was honoured for his clinical innovation, research leadership, and longstanding dedication to improving patient outcomes. The citation was delivered by Professor Juliet Wright, Dean of the Medical School, who highlighted the enduring impact of Professor Langley’s work in the field of urology.
This distinction marks a significant milestone in Professor Langley’s career and reflects his continued commitment to excellence in prostate cancer care, education, and translational research.
🎥 The full ceremony is available to view online: University of Surrey Graduation Ceremony
📌 Citation begins at 47:13
📌 Professor Langley’s speech begins at 54:57
A groundbreaking new clinical trial—the LDR BURST Study—is set to begin recruitment. Led by Dr Carla Perna and Dr William Hayhurst, the trial will compare two advanced radiotherapy techniques: Low Dose Rate (LDR) Brachytherapy and Stereotactic Body Radiotherapy (SBRT).
Professor Stephen Langley of Royal Surrey Cancer Centre, alongside Professor Frank Chinegwundoh of St George’s University of London, have written a letter to the editor of The Times in response to the article “Screening every man for prostate cancer isn’t as helpful as it sounds.”
On 26 March 2025, Professor Langley and colleagues led a landmark initiative by bringing the Man Van to the House of Commons, offering on-site prostate cancer testing to Members of Parliament and parliamentary staff.
Professor Langley was honoured to speak at the All-Party Parliamentary Group (APPG) on Prostate Cancer at the House of Commons this week, joining fellow clinicians, researchers, and policymakers to discuss the future of prostate cancer diagnostics and care across the UK.
The treatment selector table will help you to discuss with your partner and your healthcare team if you are suitable for prostate brachytherapy.
Prostate brachytherapy is the only minimally invasive surgical treatment option recommended by NICE
Latest data from The Prostate Brachytherapy Centre shows
The Prostate Cancer Charity is aiming to put prostate cancer on the top of everyone’s agenda to show it really does matter.
The Prostate Brachytherapy Advisory Group has released a video entitled Prostate Brachytherapy….because relationships matter’ to highlight the impact that treatment choice may have on relationships.